Versant Capital Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$259K Sell
11,570
-3,937
-25% -$92.6K 0.02% 527
2026
Q2
$351K Buy
15,507
+5,829
+60% +$131K 0.03% 417
2026
Q1
$218K Sell
9,678
-1,742
-15% -$40K 0.02% 556
2025
Q4
$272K Buy
11,420
+3,481
+44% +$86.6K 0.03% 396
2025
Q3
$209K Sell
7,939
-1,012
-11% -$26K 0.03% 461
2025
Q2
$256K Buy
8,951
+2,303
+35% +$61.8K 0.04% 377
2025
Q1
$166K Buy
6,648
+6,208
+1,411% +$148K 0.03% 477
2024
Q4
$10K Buy
+440
New +$9.6K ﹤0.01% 1398

Other funds holding FMS

Versant Capital Management's FMS Position: Q3 2026 in Review

Versant Capital Management reduced its Fresenius Medical Care (FMS) stake by 25% in Q3 2026, selling an estimated $92.6K and leaving 11,570 shares worth $259K. The position accounts for 0.02% of the portfolio, ranked #527.

Versant Capital Management first reported a position in FMS in Q4 2024 and has held it in 8 quarters since. The position peaked at $351K in Q2 2026. 191 funds tracked by Wall St. Rank hold FMS as of Q3 2026.

  • Versant Capital Management held 11,570 shares of Fresenius Medical Care worth $259K as of Q3 2026.
  • Versant Capital Management sold 3,937 Fresenius Medical Care shares in Q3 2026, an estimated $92.6K.
  • Fresenius Medical Care made up 0.02% of Versant Capital Management's portfolio in Q3 2026, its #527 holding.
  • Versant Capital Management first reported a position in Fresenius Medical Care in Q4 2024 and has held it in 8 quarters since.
  • Versant Capital Management's Fresenius Medical Care position peaked at $351K in Q2 2026.
  • 191 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.